MoviePass sold unlimited movies for $9.95, betting scale would fix the math

In 2017 MoviePass announced a no-contract subscription: unlimited movies in theaters, no blackout dates, for a flat $9.95 monthly fee, accepted at more than 91 percent of U.S. theaters, pitching itself as disrupting the industry the way Netflix and Redbox had.

The market response was immediate: churn of 4.2 percent in month one falling to 2.4 percent in month two, monthly retention above 96 percent, and subscriber counts racing toward the millions as parent Helios and Matheson funded the growth.

The company paid theaters full ticket price while charging subscribers less than the price of one ticket a month. Growth itself was the product, sold to investors as data, scale and eventual bargaining power with studios and exhibitors. Subscription economics inverted the risk: the heaviest users cost the most, and the model survived only if enough light users subsidized them and something, data deals, discounts, acquisitions, materialized before the cash ran out.

Charged less than one ticket a month while paying theaters full price, betting that scale would conjure a subsidy from data or bargaining power that never existed.

The $9.95 price felt like theft, driving viral adoption and high retention.

High retention made the growth story intoxicating to investors.

But heavy users cost more than light users, so average cost per user rose with scale.

The promised leverage over theaters never materialized, so cash burn outpaced revenue.

When pricing all-you-can-eat, base it on your heaviest user's cost, not the average; if marginal cost isn't near zero, growth accelerates losses.

Churn fell from 4.2% to 2.4%, monthly retention above 96%, and subscribers raced past a million after the price cut. The definitive cautionary case of buying growth with negative unit economics, cited wherever subscription dreams meet adverse selection.